Gå till Affärer
TMT

Avidly Oyj har erhållit strategisk rådgivning i anknytning till Nasdaq First North Helsinki.

Avidly Oyj har erhållit strategisk rådgivning i anknytning till Nasdaq First North Helsinki.

Avidly är den mest mångsidiga marknadskommunikationsgruppen i Finland. Bolaget erbjuder ett omfattande utbud av marknadsföringskompetens, där kreativitet, strategiskt tänkande och starkt digitalt fokus förenas.

Oaklins team i Finland har agerat som Certified Advisor till Avidly på Nasdaq First North Helsinki.

Prata med transaktionsteamet

Marcus Blomqvist

Senior Advisor
Helsingfors, Finland
Oaklins Finland

Relaterade affärer

Niscon Inc. has been acquired by SGPS ShowRig
TMT

Niscon Inc. has been acquired by SGPS ShowRig

Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.

Lär dig mer
Fairfest Media has acquired WTE Miami
Företagstjänster | TMT

Fairfest Media has acquired WTE Miami

Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.

Lär dig mer
Banook, backed by Motion Equity, has acquired Fluidda
Hälsovård | TMT

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Lär dig mer